Exon-skipping antisense oligonucleotides for cystic fibrosis therapy
Open Access
- 10 January 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (3)
Abstract
Significance: Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene, which can lead to respiratory failure. To date, there is no treatment for CF caused by the CFTR- W1282X mutation located on CFTR exon 23. Nonsense-mediated messenger RNA (mRNA) decay (NMD) degrades the CFTR- W1282X mRNA, leading to low levels of functional CFTR protein. We developed a cocktail of two antisense oligonucleotides (ASOs) that promotes the skipping of exon 23 of the CFTR- W1282X mRNA. The resulting mRNA is NMD resistant and preserves the reading frame. Its translation produces CFTR-Δex23 protein that improves CFTR activity in human bronchial epithelial cells. Our results set the stage for developing an ASO therapy for CF caused by the W1282X mutation.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R37GM042699)
- HHS | NIH | National Heart, Lung, and Blood Institute (F30HL137326-04)
- HHS | NIH | National Institute of General Medical Sciences (T32GM008444)
This publication has 46 references indexed in Scilit:
- Assessing the Disease-Liability of Mutations in CFTRCold Spring Harbor Perspectives in Medicine, 2012
- TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animalsGenes & Development, 2012
- SFmap: a web server for motif analysis and prediction of splicing factor binding sitesNucleic Acids Research, 2010
- Gating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisationThe Journal of Physiology, 2009
- A meta-analysis of nonsense mutations causing human genetic diseaseHuman Mutation, 2008
- Restoration of W1282X CFTR Activity by Enhanced ExpressionAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Antisense-mediated exon skipping: A versatile tool with therapeutic and research applicationsRNA, 2007
- Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicinJournal of Clinical Investigation, 2007
- New insights into cystic fibrosis: molecular switches that regulate CFTRNature Reviews Molecular Cell Biology, 2006
- Pharmacokinetic and Toxicity Profile of a Phosphorothioate Oligonucleotide Following Inhalation Delivery to Lung in MiceAntisense and Nucleic Acid Drug Development, 2000